AskRx review
AskRx is a US telehealth platform whose board-certified physicians exclusively prescribe FDA-approved, brand-name GLP-1 medications for weight loss - no compounded drugs.
- Scores never bought
- 537 providers tracked
- Every factor auditable
- Updated June 2026
Semaglutide here is $349/mo (all doses, brand-name) — $150 above our category median of $199.
- Semaglutide
- $349/mo (all doses, brand-name)
- Tirzepatide
- $299/mo (2.5 mg dose, brand-name)
- Coverage
- All 50 states
- Brand-name
- Yes
- Oral option
- Injectable only
- Verification
- LegitScript-certified
Best for: People who want a brand-name-only GLP-1 prescriber routing to NovoCare or LillyDirect.
MatchScript's take: Our #266 pick of 537 — confirmed nationwide access.
The factor breakdown
AskRx on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $349/mo (all doses, brand-name) puts Budget Fit at a below-par 33 — above the budget tiers.
Confirmed all-50-state access means it can usually prescribe within days, for a solid 87 on Speed to Start.
AskRx adds brand-name access on top of injectables, for a middling 79 on Formulary Match.
Support lands at a below-par 72 — lighter, meds-first support.
Flexibility scores a below-par 20 — fewer levers to flex your plan.
LegitScript certification and clear public disclosures put Transparency at a strong 90.
Pricing in context
How AskRx's monthly price sits against the category median and the cheapest provider we track.
What we like
- Prescribes only FDA-approved brand-name GLP-1s, no compounded drugs
- LegitScript approved and HIPAA compliant
- Board-certified physicians trained in obesity medicine
- Transparent dose-based pricing published on site
- Available in all 50 states
The caveats
- Cash-pay model; medication cost billed separately by the pharmacy
- Does not dispense medication itself, so fulfillment depends on third-party pharmacies
- No compounded lower-cost alternative offered
- Specific list of supported states is not published
Who it's for — and who should skip it
AskRx is for people who want a brand-name-only GLP-1 prescriber routing to NovoCare or LillyDirect.
Skip it if that doesn't sound like you. A closer fit may be SkinnyRx (Match Score 64) — or take the quiz to see where AskRx lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
AskRx against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | AskRxthis provider | CoreAge Rxour #1 | Boston Medical Groupclosest scorer |
|---|---|---|---|
| Sema price | $349/mo (all doses, brand-name) | $99/mo at every dose | $325/mo |
| Coverage | All 50 states | All 50 states | 7 states |
| Formulary | Injectable + brand | Injectable | Injectable |
| Match Score | 63 · C | 91 · A− | 63 · C |
AskRx, answered
Is AskRx legit?
Yes — AskRx is LegitScript-certified, a third-party check that a telehealth pharmacy operates within the rules. It dispenses FDA-approved brand-name medication rather than the compounded formulas most programs here sell, which is why its pricing sits higher; confirm your prescriber is US-licensed at intake.
How much does AskRx cost?
AskRx lists compounded semaglutide from $349/mo (all doses, brand-name) and tirzepatide from $299/mo (2.5 mg dose, brand-name) — above our category median of $199/mo. These are the provider's public figures at our last review (June 2026); confirm on their site, since some teaser tiers step up after month one.
Does AskRx ship to my state?
Yes — AskRx reports availability in all 50 states, so most people can start within days.
AskRx vs SkinnyRx — which should I pick?
They score within a few points of each other: AskRx at 63/100 and SkinnyRx at 64/100, so neither wins on the headline number. AskRx is the better fit for people who want a brand-name-only GLP-1 prescriber routing to NovoCare or LillyDirect. SkinnyRx suits shoppers who want a tablet as well as an injection on either molecule, and who read the term attached to an advertised rate before they read the number. Run the quiz and the weighting shifts to whichever of those matters more to you.
Pricing & state data last verified June 2026 from AskRx's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on AskRx's site. Not medical advice; see our disclosure.
Semaglutide here is $349/mo (all doses, brand-name) — $150 above our category median of $199. Tirzepatide is $299/mo (2.5 mg dose, brand-name). It scores highest on what it is willing to publish up front. Best suited to people who want a brand-name-only GLP-1 prescriber routing to NovoCare or LillyDirect. If that is not you, SkinnyRx is the closest thing to it here.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest AskRx here.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match84/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry in this ranking.84/100
- #3Match83/ 100EdenA polished, high-disclosure compounded program with strong nationwide coverage and hands-on support.83/100
- #4Match85/ 100RoA heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.85/100
- #5Match85/ 100No BS RXThe highest Transparency score here, and it is not close: twenty-four prices on one public page and four dispensing pharmacies named with street addresses.85/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| BloomWell Rx#267 | 63 | $202/mo | $253/mo | Coverage not published | Alternatives | Visit |
| Society of You#268 | 63 | $279/mo (promotional rate, compounded) | $425/mo (compounded) | Coverage not published | Alternatives | Visit |
| ARSYNL Rx#269 | 63 | $233/mo (compounded) | $233/mo | Coverage not published | Alternatives | Visit |
| Levers Health#270 | 63 | $251/mo | $402/mo | Coverage not published | Alternatives | Visit |
| LifeRx.md#271 | 63 | $174/mo | $174/mo | All 50 states | Alternatives | Visit |
| Willow#272 | 63 | $299/mo (starting dose, compounded) | $399/mo (starting dose, compounded) | Coverage not published | Alternatives | Visit |
| Avono Health#273 | 63 | $269/mo (compounded) | $349/mo (compounded) | Coverage not published | Alternatives | Visit |
| Fitstry#274 | 63 | $271/mo | $369/mo | Coverage not published | Alternatives | Visit |
| Lemonaid Health#275 | 63 | $353/mo | Not disclosed | All 50 states | Alternatives | Visit |
| Super Healthy Rx#276 | 63 | $199/mo | $249/mo | Coverage not published | Alternatives | Visit |
| Ascend Medical#277 | 63 | $122/mo | $130/mo | 2 states | Alternatives | Visit |
| Bayan Health#278 | 63 | $129/mo (billed monthly against a two- to three-month protocol you owe for) | $149/mo (billed monthly against a two- to three-month protocol you owe for) | Coverage not published | Alternatives | Visit |
| MEDGm#279 | 60 | $299/mo | $399/mo | All 50 states plus Washington, D.C. | Alternatives | Visit |
| FORM (by GBY)#280 | 62 | $299/mo compounded (no dose tiers) | Not disclosed | 48 states plus D.C. (excludes Alaska and Mississippi) | Alternatives | Visit |
| Jently#281 | 62 | $202/mo | $263/mo | Coverage not published | Alternatives | Visit |
| ReadyRx#282 | 62 | $253/mo | $320/mo | All 50 states | Alternatives | Visit |
| Remote Pharmacy#283 | 62 | $167/mo (all doses, compounded) | $350/mo | Coverage not published | Alternatives | Visit |
| Green Cap Health#284 | 62 | $179/mo | $279/mo | Texas only | Alternatives | Visit |
| Nirwana Health#285 | 62 | $151/mo | $202/mo | Coverage not published | Alternatives | Visit |
| Velvet Rx#286 | 62 | $325/mo | $283/mo | Coverage not published | Alternatives | Visit |
| Coivas#287 | 62 | $171/mo | $273/mo | Coverage not published | Alternatives | Visit |
| Emerge Weight Loss#288 | 62 | Not disclosed | $244/mo | Coverage not published | Alternatives | Visit |
| LunaRx#289 | 62 | $199/mo (starting dose, compounded) | Not disclosed | Coverage not published | Alternatives | Visit |
| Lyfe Rx#290 FDA issued Lyfe Rx a warning letter in September 2025. See FDA's warning-letter database. | 62 | $205/mo | $273/mo | Coverage not published | Alternatives | Visit |
AskRx is ranked on our best semaglutide providers, best tirzepatide providers, best GLP-1 programs and best brand-name GLP-1 providers boards, scored on the same six factors as every other provider there.